MedTrace Logo

Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study

NCT01862861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2014-07-31

No results posted yet for this study

Summary

Bioidentical Hormone Replacement Therapy (BHRT) to assess a change in the number of various menopausal symptoms such as hot flashes and night sweats in surgically or naturally induced peri or post-menopausal women.

Conditions

Sponsors & Collaborators

  • Medimix Specialty Pharmacy, LLC

    lead INDUSTRY

Principal Investigators

  • Benjamin J Epstein, PharmD · The Medimix Specialty Pharmacy, LLC

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01862861 on ClinicalTrials.gov